INDP Indaptus Corp Total Debt to Capital

The historical price chart for the total debt-to-equity ratio of Indaptus Therapeutics (INDP) is 0.00. Indaptus Therapeutics (INDP) implements ESG principles, minimizing environmental impact through the safe recycling of reagents. The operating model relies on external contractors for testing, which eliminates commodity risks. The business develops universal cancer immunotherapy methods, targeting the massive global biotechnology market and leading oncology centers.

The ratio determines the proportion of borrowed liabilities to equity, reflecting the extent to which the business's financial stability depends on external lending. By analyzing the current debt load relative to equity through GURU.Markets tools, an investor assesses the risk of default, which is critical for Indaptus Therapeutics (INDP), as its capital-intensive developments in cell immunotherapy and complex certifications require colossal investments.